Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2804PDF: 1097HTML: 121 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1187PDF: 606HTML: 6802 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1415PDF: 692HTML: 1381cover letter: 214 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1264PDF: 477HTML: 18612Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2318PDF: 1340HTML: 17093Bassan Fig.1: 146Bassan Fig.2: 159Bassan Fig.4: 142Fig.3: 196 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2602PDF: 812HTML: 5230 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1419PDF: 827HTML: 3124 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1349PDF: 1240HTML: 461 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4700PDF: 1330HTML: 1918Untitled: 184Untitled: 179 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2137PDF: 1550HTML: 506 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2198PDF: 1610HTML: 312 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1311PDF: 608HTML: 3104 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1982PDF: 827HTML: 2206Table 1: 182Table 2: 202Table 3: 196Table 4: 201Table 5: 197Tble 6: 189Cover Letter: 210Greene Tab.7: 199 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3375PDF: 1486HTML: 4016 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2108PDF: 1167HTML: 647 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1658PDF: 1247HTML: 265 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3656PDF: 903HTML: 6721 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4816PDF: 2861HTML: 2310







